Talk One Title: Local Recurrence of Breast Cancer: Therapeutic Mastectomy and the Role of CPM
Presenter: Candice N. Santoro, DO
Talk Two Title: Personalizing Management of Local and Regionally Recurrent Breast Cancer: Opportunity with Neoadjuvant Systemic and Endocrine Therapies
Presenter: Mary R. Mrdutt, MD, MS
LEARNING OBJECTIVES
Upon completion of this activity, participants should be able to:
- Define locoregional recurrence, associated risk factors, and treatment recommendations
- Assess data and guidelines surrounding contralateral prophylactic mastectomy (CPM) for index breast cancer
- Identify factors contributing to CPM at the time of mastectomy for ipsilateral breast tumor recurrence (IBTR)
- Examine how this information can guide patient education and assist with surgical planning
- Discuss current guidelines for management of local and regionally recurrent breast cancer
- Summarize institutional data regarding neoadjuvant systemic therapy for triple negative and HER2+ local and regionally recurrent breast cancer
- Recognize candidates for neoadjuvant endocrine therapy to assess endocrine responsiveness in patients with ER+ HER2- local and regionally recurrent breast cancer
ATTENDANCE / CREDIT
Text the session code (provided only at the session) to 507-200-3010 within 48 hours of the live presentation to record attendance. All learners are encouraged to text attendance regardless of credit needs. This number is only used for receiving text messages related to tracking attendance. Additional tasks to obtain credit may be required based on the specific activity requirements and will be announced accordingly. Swiping your badge will not provide credit; that process is only applicable to meet GME requirements for Residents & Fellows.
TRANSCRIPT
Any credit or attendance awarded from this session will appear on your Transcript.
For disclosure information regarding Mayo Clinic School of Continuous Professional Development accreditation review committee member(s) and staff, please go here to review disclosures.

Facebook
X
LinkedIn
Forward